[HTML][HTML] The race to develop oral SERDs and other novel estrogen receptor inhibitors: recent clinical trial results and impact on treatment options
Y Wang, SC Tang - Cancer and Metastasis Reviews, 2022 - Springer
Hormonal therapy plays a vital part in the treatment of estrogen receptor–positive (ER+)
breast cancer. ER can be activated in a ligand-dependent and independent manner …
breast cancer. ER can be activated in a ligand-dependent and independent manner …
[HTML][HTML] The race to develop oral SERDs and other novel estrogen receptor inhibitors: recent clinical trial results and impact on treatment options
Y Wang, SC Tang - Cancer Metastasis Reviews, 2022 - ncbi.nlm.nih.gov
Hormonal therapy plays a vital part in the treatment of estrogen receptor–positive (ER+)
breast cancer. ER can be activated in a ligand-dependent and independent manner …
breast cancer. ER can be activated in a ligand-dependent and independent manner …
The race to develop oral SERDs and other novel estrogen receptor inhibitors: recent clinical trial results and impact on treatment options
Y Wang, SC Tang - Cancer metastasis reviews, 2022 - pubmed.ncbi.nlm.nih.gov
Hormonal therapy plays a vital part in the treatment of estrogen receptor-positive (ER+)
breast cancer. ER can be activated in a ligand-dependent and independent manner …
breast cancer. ER can be activated in a ligand-dependent and independent manner …
The race to develop oral SERDs and other novel estrogen receptor inhibitors: recent clinical trial results and impact on treatment options
Y Wang, SC Tang - Cancer and Metastasis Reviews, 2022 - search.proquest.com
Hormonal therapy plays a vital part in the treatment of estrogen receptor–positive (ER+)
breast cancer. ER can be activated in a ligand-dependent and independent manner …
breast cancer. ER can be activated in a ligand-dependent and independent manner …
[PDF][PDF] The race to develop oral SERDs and other novel estrogen receptor inhibitors: recent clinical trial results and impact on treatment options
Y Wang, SC Tang - Cancer and Metastasis Reviews, 2022 - researchgate.net
Hormonal therapy plays a vital part in the treatment of estrogen receptor–positive (ER+)
breast cancer. ER can be activated in a ligand-dependent and independent manner …
breast cancer. ER can be activated in a ligand-dependent and independent manner …
The race to develop oral SERDs and other novel estrogen receptor inhibitors: recent clinical trial results and impact on treatment options.
Y Wang, SC Tang - Cancer Metastasis Reviews, 2022 - europepmc.org
Hormonal therapy plays a vital part in the treatment of estrogen receptor-positive (ER+)
breast cancer. ER can be activated in a ligand-dependent and independent manner …
breast cancer. ER can be activated in a ligand-dependent and independent manner …
The race to develop oral SERDs and other novel estrogen receptor inhibitors: recent clinical trial results and impact on treatment options.
Y Wang, SC Tang - Cancer & Metastasis Reviews, 2022 - search.ebscohost.com
Hormonal therapy plays a vital part in the treatment of estrogen receptor–positive (ER+)
breast cancer. ER can be activated in a ligand-dependent and independent manner …
breast cancer. ER can be activated in a ligand-dependent and independent manner …
[引用][C] The race to develop oral SERDs and other novel estrogen receptor inhibitors: recent clinical trial results and impact on treatment options
Y Wang, SC Tang - Cancer and Metastasis Reviews, 2022 - europepmc.org
Hormonal therapy plays a vital part in the treatment of estrogen receptor–positive (ER+)
breast cancer. ER can be activated in a ligand-dependent and independent manner …
breast cancer. ER can be activated in a ligand-dependent and independent manner …